Establishment Labs Holdings Stock Performance
| ESTA Stock | USD 46.07 0.50 1.10% |
Establishment Labs has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.78, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Establishment Labs will likely underperform. Establishment Labs right now shows a risk of 4.55%. Please confirm Establishment Labs semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Establishment Labs will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Establishment Labs Holdings are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Establishment Labs may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
Actual Historical Performance (%)
One Day Return 1.1 | Five Day Return 7.49 | Year To Date Return 73.26 | Ten Year Return 86.14 | All Time Return 86.14 |
1 | Establishment Labs Holdings Inc Shares Down 3.27 percent on Oct 8 | 10/08/2024 |
2 | Sera Prognostics, Inc. Reports Q3 Loss, Lags Revenue Estimates | 11/06/2024 |
3 | Establishment Labs GAAP EPS of -0.59 beats by 0.02, revenue of 40.2M misses by 0.25M | 11/07/2024 |
4 | Establishment Labs Holdings Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth ... | 11/08/2024 |
5 | Establishment Labs Holdings Inc. Q3 2024 Earnings Call Transcript | 11/11/2024 |
6 | ABRUMADOS POR ESTA TEMPORADA NAVIDEA CONSIDEREN UN RBOL DE NAVIDAD NATURAL | 11/13/2024 |
7 | PURA VIDA INVESTMENTS, LLC Acquires New Holdings in Sonendo Inc | 11/14/2024 |
8 | Establishment Labs Holdings Inc Trading 6.48 percent Higher on Nov 20 | 11/20/2024 |
9 | Stonepine Capital Management LLC Makes New 3.25 Million Investment in Establishment Labs Holdings Inc. | 11/27/2024 |
| Begin Period Cash Flow | 66.4 M |
Establishment |
Establishment Labs Relative Risk vs. Return Landscape
If you would invest 4,582 in Establishment Labs Holdings on August 30, 2024 and sell it today you would earn a total of 25.00 from holding Establishment Labs Holdings or generate 0.55% return on investment over 90 days. Establishment Labs Holdings is currently generating 0.109% in daily expected returns and assumes 4.5521% risk (volatility on return distribution) over the 90 days horizon. In different words, 40% of stocks are less volatile than Establishment, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Establishment Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Establishment Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Establishment Labs Holdings, and traders can use it to determine the average amount a Establishment Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0239
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ESTA | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Establishment Labs is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Establishment Labs by adding it to a well-diversified portfolio.
Establishment Labs Fundamentals Growth
Establishment Stock prices reflect investors' perceptions of the future prospects and financial health of Establishment Labs, and Establishment Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Establishment Stock performance.
| Return On Equity | -2.23 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.46) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 1.47 B | ||||
| Shares Outstanding | 28.76 M | ||||
| Price To Earning | (20.11) X | ||||
| Price To Book | 40.07 X | ||||
| Price To Sales | 8.66 X | ||||
| Revenue | 165.15 M | ||||
| Gross Profit | 106.59 M | ||||
| EBITDA | (58.31 M) | ||||
| Net Income | (78.5 M) | ||||
| Cash And Equivalents | 65.35 M | ||||
| Cash Per Share | 2.68 X | ||||
| Total Debt | 192.22 M | ||||
| Current Ratio | 4.27 X | ||||
| Book Value Per Share | 1.16 X | ||||
| Cash Flow From Operations | (88.51 M) | ||||
| Earnings Per Share | (2.59) X | ||||
| Market Capitalization | 1.33 B | ||||
| Total Asset | 268.64 M | ||||
| Retained Earnings | (360.1 M) | ||||
| Working Capital | 117.75 M | ||||
| Current Asset | 60.91 M | ||||
| Current Liabilities | 45.78 M | ||||
About Establishment Labs Performance
By analyzing Establishment Labs' fundamental ratios, stakeholders can gain valuable insights into Establishment Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Establishment Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Establishment Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 501.56 | 526.64 | |
| Return On Tangible Assets | (0.30) | (0.32) | |
| Return On Capital Employed | (0.31) | (0.29) | |
| Return On Assets | (0.29) | (0.31) | |
| Return On Equity | (4.27) | (4.05) |
Things to note about Establishment Labs performance evaluation
Checking the ongoing alerts about Establishment Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Establishment Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Establishment Labs had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 165.15 M. Net Loss for the year was (78.5 M) with profit before overhead, payroll, taxes, and interest of 106.59 M. | |
| Establishment Labs Holdings currently holds about 65.35 M in cash with (88.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. | |
| Establishment Labs has a very weak financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Stonepine Capital Management LLC Makes New 3.25 Million Investment in Establishment Labs Holdings Inc. |
- Analyzing Establishment Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Establishment Labs' stock is overvalued or undervalued compared to its peers.
- Examining Establishment Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Establishment Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Establishment Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Establishment Labs' stock. These opinions can provide insight into Establishment Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |